Fabrice Vincent
Lieff Cabraser Heimann & Bernstein, LLP
Practice Areas
Bar Information
Admitted to practice in California, 1992; U.S. District Court, Northern District of California, Central District of California, Eastern District of California, Ninth Circuit Court of Appeals, 1992.
Education
Cornell Law School (J.D., cum laude, 1992); University of California at Berkeley (B.A., 1989).
Awards
"Northern California Super Lawyer," Law & Politics, 2006-2008.
Publications
Co-Author with Elizabeth J. Cabraser, “Class Actions Fairness Act of 2005,” California Litigation, Vol. 18, No. 3 (2005); Co-Editor, California Class Actions Practice and Procedures (2003-06); Co-Author, "Ethics and Admissibility: Failure to Disclose Conflicts of Interest in and/or Funding of Scientific Studies and/or Data May Warrant Evidentiary Exclusions," Mealey's December Emerging Drugs Reporter (December 2002); Co-author, "The Shareholder Strikes Back: Varied Approaches to Civil Litigation Claims Are Available to Help Make Shareholders Whole," Mealey's Emerging Securities Litigation Reporter (September 2002); Co-author, "Decisions Interpreting California's Rules of Class Action Procedure," Survey of State Class Action Law (ABA 2000-06), updated and re-published in 5 Newberg on Class Actions (2001-06); Coordinating Editor and Co-author of California section of the ABA State Class Action Survey (2001-06); Co-Editor-In-Chief, Fen-Phen Litigation Strategist (Leader Publications 1998-2000) and Author of "Off-Label Drug Promotion Permitted" (Oct. 1999); Co-author, "The Future of Prescription Drug Products Liability Litigation in a Changing Marketplace," and "Six Courts Certify Medical Monitoring Claims for Class Treatment," 29 Forum 4 (Consumer Attorneys of California 1999); Co-author, "Class Certification of Medical Monitoring Claims in Mass Tort Product Liability Litigation" (ALI-ABA Course of Study 1999); Co-author, "How Class Proofs of Claim in Bankruptcy Can Help in Medical Monitoring Cases," (Leader Publications 1999); Co-author, Introduction, "Sanctioning Discovery Abuses in the Federal Court," (LRP Publications 2000); "With Final Approval, Diet Drug Class Action Settlement Avoids Problems That Doomed Asbestos Pact," (Leader Publications 2000).
Member
State Bar of California; Bar Association of San Francisco; American Bar Association; Association of Trial Lawyers of America; Association of Business Trial Lawyers.
About Lieff Cabraser
Lieff Cabraser Heimann & Bernstein, LLP is a fifty-plus attorney law firm that has represented plaintiffs nationwide since 1972. We have offices in San Francisco, New York and Nashville. We represent plaintiffs in class and group actions and in individual lawsuits in cases involving substantial losses. For the last six years, the National Law Journal has selected Lieff Cabraser as one of the top plaintiffs' law firms in the nation.
Admitted to practice in California, 1992; U.S. District Court, Northern District of California, Central District of California, Eastern District of California, Ninth Circuit Court of Appeals, 1992.
Education
Cornell Law School (J.D., cum laude, 1992); University of California at Berkeley (B.A., 1989).
Awards
"Northern California Super Lawyer," Law & Politics, 2006-2008.
Publications
Co-Author with Elizabeth J. Cabraser, “Class Actions Fairness Act of 2005,” California Litigation, Vol. 18, No. 3 (2005); Co-Editor, California Class Actions Practice and Procedures (2003-06); Co-Author, "Ethics and Admissibility: Failure to Disclose Conflicts of Interest in and/or Funding of Scientific Studies and/or Data May Warrant Evidentiary Exclusions," Mealey's December Emerging Drugs Reporter (December 2002); Co-author, "The Shareholder Strikes Back: Varied Approaches to Civil Litigation Claims Are Available to Help Make Shareholders Whole," Mealey's Emerging Securities Litigation Reporter (September 2002); Co-author, "Decisions Interpreting California's Rules of Class Action Procedure," Survey of State Class Action Law (ABA 2000-06), updated and re-published in 5 Newberg on Class Actions (2001-06); Coordinating Editor and Co-author of California section of the ABA State Class Action Survey (2001-06); Co-Editor-In-Chief, Fen-Phen Litigation Strategist (Leader Publications 1998-2000) and Author of "Off-Label Drug Promotion Permitted" (Oct. 1999); Co-author, "The Future of Prescription Drug Products Liability Litigation in a Changing Marketplace," and "Six Courts Certify Medical Monitoring Claims for Class Treatment," 29 Forum 4 (Consumer Attorneys of California 1999); Co-author, "Class Certification of Medical Monitoring Claims in Mass Tort Product Liability Litigation" (ALI-ABA Course of Study 1999); Co-author, "How Class Proofs of Claim in Bankruptcy Can Help in Medical Monitoring Cases," (Leader Publications 1999); Co-author, Introduction, "Sanctioning Discovery Abuses in the Federal Court," (LRP Publications 2000); "With Final Approval, Diet Drug Class Action Settlement Avoids Problems That Doomed Asbestos Pact," (Leader Publications 2000).
Member
State Bar of California; Bar Association of San Francisco; American Bar Association; Association of Trial Lawyers of America; Association of Business Trial Lawyers.
About Lieff Cabraser
Lieff Cabraser Heimann & Bernstein, LLP is a fifty-plus attorney law firm that has represented plaintiffs nationwide since 1972. We have offices in San Francisco, New York and Nashville. We represent plaintiffs in class and group actions and in individual lawsuits in cases involving substantial losses. For the last six years, the National Law Journal has selected Lieff Cabraser as one of the top plaintiffs' law firms in the nation.
This CLE package will satisfy all of your New York CLE requirements! The MCLEZ New York Bundle A provides 24 hours of CLE credit, including 4 hrs of Ethics, Professionalism and Diversity.
San Francisco International Law Lawyers
Renowned attorney, author, television commentator, and international expert: travel, tourism, hotel, airline, cruise, tour operator, and travel agent law, compliance and Preventive Legal CareTM
1 (415) 673-3333